Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research

What is it about?

During the past decade, there has been extraordinary hope and excitement that psychedelics may be beneficial in the treatment of many psychiatric disorders including major depressive disorder (MDD), trauma-related conditions (e.g., post-traumatic stress disorder; PTSD) and substance use disorders. Although the excitement is welcomed and the need is great, it is critical that the development of psychedelic treatments be rigorous with respect to safety as well as precise in the measurement and characterization of the actual benefit of these treatments. The overarching aims of this paper are to facilitate the interpretability and translatability of psychedelic studies and provide guidance for their future research and implementation.

Featured Image